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Immunogenetic Heterogeneity of Type 1 Diabetes in Japan
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 Type 1 diabetes is an organ-specific autoimmune disease 
characterized by T-cell mediated destruction of pancreatic
β
-cells . In Japanese population, the incidence of type 1 dia-
betes in children is very low compared to European coun-
tries. However, there are more patients with type 1 diabe-
tes in adults, including latent autoimmune diabetes in 
adults (LADA). A variety of environmental and genetic fac-
tors are involved in the development of the disease. The 
human leukocyte antigen (HLA) class II genes (termed 
IDDM1) are the major genes associated with susceptibility 
to type 1 diabetes. HLA-DRB1*0405-DQB1*0401, HLA-DRB1* 
0901-DQB1*0303 and HLA-DRB1*0802-DQB1*0302 are three 
major haplotypes in Japanese patients with type 1 diabetes. 
Other genetic factors reported in Japanese type 1 diabetes 
include the polymorphisms in insulin gene (IDDM2), CTLA-4 
gene (IDDM12), MICA gene, Neuro D/Beta 2 gene, and IL-10 
gene. 
 The circulating autoantibodies to multiple islet autoantigens 
including GAD, insulin, and IA-2 are the important 
immunological features of type 1 diabetes. The prevalences 
of anti-islet autoantibodies in patients with Japanese type 
1 diabetes are 60-70% for GAD autoantibodies, 45-50% for 
insulin autoantibodies (IAA), and 60-65% for IA-2 
autoantibodies at disease onset, which are similar to those 
reported in Caucasian patients. With combinatorial analysis 
of these autoantibodies ninety percent of patients express 
at least one of these autoantibodies and are classified as 
immune-mediated type 1 diabetes. Although the majority of 
patients with type 1 diabetes are young, lean, and ketosis-
prone, there are number of patients with type 1 diabetes 
initially diagnosed as having type 2 diabetes at disease 
onset. These slow-onset diabetic patients with anti-islet
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autoantibodies often progress toward insulin-deficient state 
within several years after diagnosis. High level of GAD 
autoantibodies has a high predictive value for future 
insulin deficiency in slow-onset patients with type 1 diabe-
tes. In conclusion, Japanese patients with type 1 diabetes 
are clinically heterogenous and the determination of 
immunological and genetic features are helpful to clarify 
the characteristics of the Japanese type 1 diabetic syn-
drome. 
     ACTA MEDICA NAGASAKIENSIA 47: 81-88, 2002
Key Words: type 1 diabetes, autoantibodies, genetics, hetero-
            geneity, immunology, autoantigen
Introduction
 Multiple types of diabetes mellitus have been de-
fined by the recent reports of an American Diabetes 
Association Expert Committee and a WHO 
Consultation based on our current understanding of 
pathogenesis rather than the requirement for insulin 
therapy' , 2'. Type 1 diabetes is often associated with 
chronic and progressive autoimmune destruction of 
islet l9 -cells with a long prodromal phase. This type 
of type 1 diabetes is classified as "immune-mediated" 
(type 1A) diabetes. Another type of type 1 diabetes is 
a disease with no evidence of an autoimmune disorder 
at disease onset and classified as "idiopathic" (type 113) 
diabetes . On the other hand, type 2 diabetes results 
from defect in insulin secretion, almost always with a 
major contribution from insulin resistance. 
 Type 1 A diabetes is characterized by T cell-
mediated destruction of p -cells in genetically suscepti-
ble individuals" and is associated with the presence 
of autoantibodies to multiple islet cell antigens". 
During the past decade, there has been a remarkable 
increase in the number of candidate genes for suscep-
tibility of type 1 diabetes and biochemically defined 
autoantigens found to be targets of the autoimmune 
process.
 The risk for individuals of developing type 1 diabe-
tes varies remarkably based on the country of resi-
dence and race. In Caucasian populations, including 
those in Northern Europe, type 1 diabetes incidence 
rates are high with rates in excess of 30 cases/ 
year/ 100,000 individuals. In contrast, Japanese popula-
tion have one of the lowest incidence rate of type 1 
diabetes in the world, 1.6 cases/year/100,000 individu-
als, suggesting that Japanese population may lack an 
important susceptibility gene or may have a unique 
protective gene of type 1 diabetes"". Rigorous efforts 
are being made to characterize the immunogenetic 
heterogeneity of type 1 diabetes in Japan. In this 
paper we review the genetic and immunological re-
search findings on Japanese type 1 diabetes and at-
tempt to clarify the characteristics of the Japanese 
type 1 diabetic syndrome.
GENETICS OF TYPE 1 DIABETES IN JAPAN
 As type 1 diabetes is an etiologically and geneti-
cally heterogeneous disease, the expression of disease 
phenotype is influenced by a number of susceptibility 
genes as well as environmental factors. Recent ad-
vances in research on type 1 diabetes include the 
genome-wide search for susceptibility genes". More 
than 20 putative diabetes-predisposing genes identified 
by linkage and association studies (Table 1). Among 
these, most of the genetic susceptibility for type 1 dia-
betes is determined by HLA genes. These HLA region 
susceptibility genes are collectively referred to as 
IDDM 1. Although genes responsible for most IDDM 
loci are still unknown, the gene for IDDM2, IDDM12, 
and IDDM 18 have been identified. In this section, we 
will review the HLA and non-HLA genes that contrib-
ute to diabetes susceptibility and heterogeneity in 
Japanese type 1 diabetes.
A. HLA Genes (IDDM 1)
 Many studies have shown that the human leukocyte 
antigen (HLA) class II loci on chromosome 6g21.3 in-
cluding HLA-DRB 1, DQB 1 and DQA 1, are most 
strongly associated with diabetes risk. HLA class II 
haplotypes associated with Japanese type 1 diabetes 
are shown in Table 2" . DRB1*0405-DQA1*0301-
DQB1*0401, DRB1*0901-DQA1*0301-DQB1*0303 and 
DRB1*0802-DQA1*0301-DQB1*0302 are three major 
diabetes-susceptible haplotypes in Japanese. In con-
trast, DQA1*0301-DQB1*0302 with HLA-DRB1*0401, 
*0402 or *0405 alleles and DRB1*0301 -DQA1*0501-
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Table 1. Putative susceptibility loci for type 1 diabetes
                       Locus Candidate gene 
IDDMI 6g21.3 HLA 
IDDM2 11p15 Insulin gene 
IDDM3 15q26 





IDDM9 3q2l-q25 CD80 and CD86 
IDDM10 10pll-qll 
IDDM 11 14g24.3-q31 
IDDM12 2q33 CTLA-4 gene 
IDDM 13 2q35 
IDDM14 -
IDDM 15 6g21 
IDDM16 14q32.3 
IDDM 17 10g25 
IDDM18 5g31.1-g33.1 IL-12 p4o gene 
Unnamed 1g42 
Unnamed 16q22-q24 
Unnamed l9p 13 
Unnamed 19q 13 
Unnamed Xp 13-p l l 
Unnamed 7pI3 Glucokinase gene 
Unnamed 12g14-q15 Interferon y gene
Table 2. HLA class II haplotypes associated with Japanese 
type 1 diabetes
ORB 1 DQA 1 DQB 1 Type 1 diabetes Control Relative risk 
                  (%) (%) 
   Susceptibility 
0405 0301 0401 35-57 20-28 3-4 
0901 0301 0303 35-52 30-33 1-2 
0802 0301 0302 10-14 1-3 4-10 
0405 0301 0302 3-9 -0 6-27 
0301 0501 0201 0-5 0-1 1-5 
     Resistance 
1501 0102 0602 ~1 13-22 ~0.1 
1502 0103 0601 2-4 14-23 0.1-0.2 
0406 0301 0302 0-1 5-7 0.1-0.2
                         7) From Awata and Kanazawa
,
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DQB 1 *0201 are the haplotypes associated with the 
highest risk for type 1 diabetes in Caucasians. The lat-
ter haplotype is rare in Japanese population but 
DQB 1 *0201 is almost universally found in excess 
among patients with type 1 diabetes compared to con-
trol even in Japanese". Kawabata and coworkers cur-
rently reported an interesting association of genotypic 
combinations of Asian DRB 1-DQB 1 haplotypes with 
susceptibility to type 1 diabetes in Japanese". The fre-
quencies of heterozygotes and homozygotes with 
DRB 1 *0405-DQB 1 *0401 are similarly higher in patients 
than in control subjects. In contrast, homozygotes, but 
not heterozygotes, with DRB1*0901-DQB1*0303 are 
more frequent in patients with type 1 diabetes than in 
control subjects. They suggest that the contribution of 
HLA haplotypes to the genetic susceptibility to type 1 
diabetes differs depending on the genotypic combina-
tion of HLA haplotypes: the DRB 1 *0405-DQB 1 *0401 
haplotype shows best fit in a dominant model, 
whereas the DRB 1 *0901-DQB 1 *0303 haplotype fits in 
a recessive model. The DR2 haplotypes, DRB 1 * 1501-
DQA 1 *0102-DQB 1 *0602 and DRB 1 * 1502-DQA 1 *0103-
DQB 1 *0601, were negatively associated with type 1 
diabetes in Japanese. The latter haplotype is rare in 
Caucasians and Blacks. However, DRB 1 * 1501-DQA 1 * 
0102-DQB1*0602 is also associated with resistance in 
Caucasians, and the similar ORB 1 * 1503-DQA 1 *0102-
DQB 1 *0602 is associated with resistance in Blacks, 
suggesting that DQA 1 *0102-DQB 1 *0602 is a primary 
protective molecules.
B. Non-HLA Region Genes
 Table 3 summarizes the non-MHC genes which has 
been studied in the association with susceptibility to 
or heterogeneity of type 1 diabetes in Japanese.
Table 3. Non-MHC genes associated with susceptibility to or 
heterogeneity of type 1 diabetes
 Gene Chr. Region Allele Comment. 
                              class I,II,I11 No association with susceptibility 12, 13)   INS 
         l lpl5 5' VNTR RUs in class 
(IDDM2) Association with susceptibility 14) I 
         2q35- 
D2S1753E 161,165mu No association with susceptibility   IA-2 
           36.1 or heterogeneity sod 
                                                                                                                                     - ------------------- - -
                                       No association with susceptibility in child 
                       3' onset diabetes 17' 
CTLA-4 untranslated (AT)n Association with susceptibility in adult 
(IDDM12) 2q33 onset diabetes 18) 
                  at position 49 Association with heterogeneity (acute-
                     in exon 4 onset diabetes) 20,21) 
                                                  - -- - --------
                 (GCT/AGC)n A4, 5, 5. 1 A4: association with susceptible haplotype 
, 
 MICA 6821 i
n TM region 6,9 A6: association with protective haplotype                                               5
.1: association with age-at-onset 2s 
                                       Association with susceptibility 51) 
NeuroD/ Codon 45 in G/A 
 BETA2 2q32 coding region (Ala45Thr) No association with heterogeneity (acute 
                                           onset but not slow onset) 27) 
        12g 12- 36 
 VDR )                   VDR-Fokl F/f Association with susceptibility 
         q14 
 SDF-1 10q 11 3' A/G Association with age-at-onset 37) 
                    untranslated 
          I 1g22.2- 5' promoter -607 C/A 
 IL 18 
.3 region -137 G/C Association with susceptibility 33)         g22 
-----------------------
                   5' promoter -1,031 C/T Association with susceptibility haplotype 
 TNF-(x 6g21.3 -857 C/T 31) 
                     region 
                              -863 C/A ------- y-- . .............. 
 IFN-y 12q4 First intron (CA)n Association with susceptibilit32) 
  ---- ------ - -_--_-__----...... .. .._.. 
                             -1082 A/G 
           1g31- 5' promoter 
  IL-10 -819 T/C Association with age-at-onset 30) 
           q32 region 
                                -592 C/A
approximately 95 % of Japanese are homozygous for 
class I alleles. Then no significant differences of class 
I or class III alleles are found between Japanese pa-
tients with type 1 diabetes and control subjects","). 
However, when class I allele was further divided 
based on the number of repeats and sequence, the 
shortest component (IS; 25-38 repeats) was associated 
with susceptibility to type 1 diabetes in Japan"'.
IDDM2: Insulin Gene
 The insulin gene (INS) on chromosome 1lp15 (IDDM 
2) has a variable number of tandem repeats (VNTR) in 
the 5' region of the gene. Polymorphisms in this non-
coding region of the insulin gene are associated with 
the risk of type 1 diabetes and influence thymic insu-
lin mRNA expression. The VNTR is comprised of 14-
to 15-bp oligonucleotides and is classified into three 
classes according to their size: class I (26-63 repeats), 
class II (approximately 80 repeats) and class III (140-
200 repeats). In Caucasians, the shortest class I allele 
is susceptible to type 1 diabetes, while the longest 
class III allele is protective",'''. In Japanese population, 
the INS-VNTR region is less polymorphic and
IDDM12: CTLA-4 Gene
 The cytotoxic T lymphocyte antigen-4 (CTLA-4) gene, 
on chromosome 2q33, encodes a receptor expressed on 
activated T cells. The CTLA-4 binds to the CD28/B7 
molecule on the antigen-presenting cell, delivers a 
negative signal to the T cell and mediates apoptosis. 
Association has been found between CTLA-4 gene 
polymorphisms, including the (AT)n microsatellite 
marker in the 3' untranslated region and the A/G 
polymorphism in the first exon of the CTLA-4 gene, 
and type 1 diabetes in separate family-based studies 
in Spanish, French, Mexican-American, Chinese, and 
Korean populations"'. The (AT)n polymorphism in the 
3' untranslated region of exon 4 of the CTLA-4 gene
was reported to represent a recessive risk factor for 
type 1 diabetes in Swedish patients"'. In Japanese 
population, it has been reported that the frequency of 
the 86-bp allele is significantly lower in child-onset, 
especially in early-onset (onset age < 5 years), pa-
tients with type 1 diabetes than that in normal con-
trol subjects"'. However, in adult-onset patients with 
type 1 diabetes, lack of associations with the (AT)n 
microsatellite was reported18'. 
 The CTLA-4 with G allele at position 49 (codon 17) 
is less effective in inhibiting the proliferation of acti-
vated T-cells than that with A allele, possibly because 
the Thr/Ala substitution in the leader peptide may 
alter endocytosis or surface tracking of the CTLA-4 
molecule"). The frequency of the G allele has been re-
ported to be associated with type 1 diabetes with 
acute-onset or insulin -depletion20' . Our data demon-
strated that the presence of IA-2 autoantibodies, but 
not GAD autoantibodies, was associated with allele 
frequencies of A/G polymorphism. As shown in Table 
4 the frequency of G allele was significantly increased 
in type 1 diabetic patients with IA-2 autoantibodies 
compared to that in IA-2 autoantibody-negative pa-
tients"). However, lack of associations between the 
A/G polymorphism and type 1 diabetes was observed 
in slow onset diabetic patients with GAD 
autoantibody-positive in adults"-22'. These results sug-
gest that the CTLA-4 gene A/G polymorphism at po-
sition 49 may contributes the mode of onset and 
immunological heterogeneity of type 1 diabetes in 
Japanese population.
Table 4. CTLA-4 gene polymorphism in Japanese patients 
with type 1 diabetes and GAD autoantibody-positive NIDDM
                           Genotype Allele 
                                                 G allele
                n GG GA AA p value p value                                                         f
requency 
Type 1 diabetes 75 44(59) 26(35) 5(6) 0.007* 114(76) 0.002* 
GAD Ab' NIDDM 51 15(29) 24(47) 12(24) 0.118* 54(53) 0.060* 
IA-2Ab' type 1 21 14(67) 7(33) 0(0) 0.028t 35(83) 0.004t 
IA-2Ab- type 1 48 18(37) 21(44) 9(19) 57(59) 
Normal controls 445 177(40) 207(46) 61(14) 561(63)
Data are n (%). *Comparison between GAD Ab' NIDDM and type 1 diabetes with normal 
controls by x2 test;tComparison between IA-2Ab' and IA-2Ab" type I diabetes by x2 test. 
Ab, autoantibodies
MICA Gene
 The MHC class I genes termed MICA (MHC class I 
chain-related genes) was identified near the HLA-B 
gene on the short arm of chromosome 623,24>. It has
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been reported that the triplet repeat microsatellite 
polymophism of (GCT/AGC)n (designated A4, A5, 
A5.1, A6, A9) in the TM region (exon 5) of MICA gene 
and an allele of A6 is strongly associated with 
Japanese patients with Behcet disease25' . In Japanese 
patients with type 1 diabetes, A4 allele was associated 
with disease susceptibility, while A6 allele showed the 
protective effect"). However, A4 allele is associated 
with a susceptible haplotype DR4 and A6 allele with 
protective haplotype, DR2, suggesting the association 
of MICA with type 1 diabetes susceptibility may be 
due to linkage disequilibrium with HLA class II 
haplotype.
Other Non-MHC Genes
 The polymorphisms (Ala45Thr) of NeuroD/BETA2 
gene, encodes a transcription factor of the insulin 
gene and is located on chromosome 2q32 where the 
IDDM7 gene has previously been mapped, has been re-
ported to be associated with predisposition of type l 
diabetes. Yamada and coworkers found a significant 
difference in Ala45Thr allele frequency between acute-
onset patients with type 1 diabetes and control sub-
jects, regardless of the presence of anti-islet 
autoantibodies. However, no difference was found be-
tween slow-onset patients with type 1 diabetes and 
control subjects, suggesting that NeuroD/BETA2 may 
affect the ability of regeneration of 9 -cells, leading to 
a difference in the onset pattern and clinical course of 
type 1 diabetes2". 
 The association between polymorphisms in the 
cytokine or cytokine receptor gene and type 1 diabe-
tes have also been reported. IL-10 has generally been 
associated with immunosuppression to prevent dia-
betes in NOD mice"). However, acceleration of dia-
betes occurs in transgenic mice with constitutive (3 -
cell expression of IL-1029'. We have recently studied 
an association between the polymorphisms in the 
IL-10 gene, located on chromosome 1g31-q32, and 
disease susceptibility to or heterogeneity of type 1 
diabetes in Japanese. The IL-10 gene promoter region 
polymorphisms were not associated with susceptibility 
to type 1 diabetes. However, the haplotype of IL-10 
gene that relates to low production of IL-10 was 
strongly associated with older age at onset"'. Biallelic 
polymorphisms in the TNF- a gene located on chro-
mosome 6q21.3 were reported to be associated with 
susceptibility to type 1 diabetes. However, this asso-
ciation was found to be secondary to their linkage 
disequilibrium with the HLA-B and HLA-DRB 1 
alleles"'. IFN- y gene located on chromosome 12q4 is 
another gene associated with predisposition to type 1
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diabetes in Japanese population, especially in patients 
with juvenile (<10 years) or abrupt-onset of diabetes"'. 
Recently, we found that the polymorphism of the IL-
18 gene located on chromosome 11g22.2-g22.3 is as-
sociated with a susceptibility to Japanese type 1 
diabetes33> 
 Vitamin D has important immunomodulatory effects 
and influences insulin secretion") and an administra-
tion of vitamin D prevents the development of diabe-
tes in the NOD mouse 35'. The initiation codon polymor-
phism (F allele/ the FF genotype) in exon 2 of the 
Vitamin D receptor gene was also reported to influ-
ence the genetic susceptibility to type 1 diabetes in 
Japan"). Stromal-derived factor (SDF)-1 (CXC chemokine 
ligand 12) is a powerful chemoattractant cytokine, 
which regulate T-cell activation and migration. The 
SDF-1 gene is located on chromosome 10gll near 
IDDM 10 and there is a polymorphism in the 3' 
untranslated region of the gene. We have found that 
the variant of the SDF-1 gene is associated with age-
at-onset of type 1 diabetes in Japanese population37.
IMMUOLOGY OF JAPANESE TYPE 1 DIABETES
 In accordance with the view that development of 
type 1 diabetes involves heterogeneous mechanisms, 
different clinical courses of fl-cell destruction have 
been reported in Japanese population. The most preva-
lent clinical classification of type 1 diabetes is abrupt-
onset with severe clinical symptoms with ketoacidosis. 
The peak age of onset of type 1 diabetes in Japan is 
10-12 years old, in accordance with the age-related 
distribution in the Caucasian population. Other sub-
type of type 1 diabetes in the Japanese population is 
a slow-onset from of diabetes as having NIDDM at 
onset. Slow-onset patients with type 1 diabetes are 
also referred as "latent autoimmune diabetes in adults 
(LADA)" or "slowly progressing IDDM"38"40'. Imagawa 
and coworkers reported another form of type 1 diabe-
tes characterized by extremely rapid onset and is as-
sociated with pancreatic exocrine inflammation among 
Japanese patients with type 1 diabetes (called as 
Fulminant type 1 diabetes)"'. These patients present 
with diabetic ketoacidosis and a low HbA 1 c level at 
disease onset indicating that the diabetes is of very 
short duration"'. Although they have severe hypergly-
cemia associated with diabetic ketoacidosis, these indi-
viduals lack the usual diabetes-related autoantibodies. 
The pathophysiologic mechanisms involved in this 
type of diabetes are now exploring by the committee 
on the study of fulminant type 1 diabetes organized 
by Japan Diabetes Society.
Autoantibodies to multiple islet autoantigens in 
Japanese type 1 diabetes
 A large number of biochemically defined autoantigens 
including insulin, GAD65, ICA512/IA-2 have been 
found to be targets of the autoimmune process which 
precedes type 1 diabetes onset"'. Expression of multi-
ple autoantibodies confers a high risk for progression 
to type 1 diabetes"'. We determined the distribution 
of autoantibodies to ICA512/IA-2, GAD, and insulin in 
Japanese type 1 diabetes patients. Of 73 new-onset pa-
tients, the prevalence was 71 % for GAD autoantibodies, 
48 % for insulin autoantibodies (IAA), 62 % for ICA512/ 
IA-2 autoantibodies, and 62 % for islet cell antibodies 
(ICA). Eighty-nine % of patients with recent onset of 
type 1 diabetes express one or more of three 
autoantibodies. Of note, eight out of 73 (11%) patients 
with type 1 diabetes were negative for all of these 
anti-islet autoantibodies and classified as having type 
113 (idiopathic) diabetes (Figure 1)44'. Table 5 summa-
rizes the comparison of diagnostic sensitivity for type 
1 diabetes for the combined analysis of biochemically 
defined islet autoantibodies versus ICA measured by 
immunohistochemistry. The sensitivity for the diagno-
sis of type 1 diabetes was markedly increased when 
the test for GAD autoantibodies was used in addition 
to the tests for other islet autoantibodies. Thus, the 
test GAD autoantibodies in addition to ICA512/ IA-2 
autoantibodies or IAA increased positivity to 86 % and 
79 %, respectively. As expected, at equal specificity, 
the combined evaluation of autoantibodies to ICA512/ 
IA-2, GAD, and insulin was more sensitive (89 %) com-
pared to ICA testing for diagnosis of type 1 diabetes.
         ICA512/IA-2 8 
                    (11%) 7
          (10%) 
       14 4 
      (19% 20 6%)
          (27%) 
     9 2 
    (12%) 9 (3%) 
GAD (12% IAA
Figure 1. Combinatorial autoantibody analysis in Japanese 
new-onset patients with type 1 diabetes (n=73) Modified from 
Sera et al, J Autoimmun 13,257-265, 1999.
Table 5. Comparison of diagnostic sensitivity for the com-
bined autoantibody analysis versus ICA
                                                 Combined analysis vs. ICA 
  Combination of Autoantibodies Type 1 diabetes positivity 
                               (n=73) 
                                           Odds ratio X2 p value 
ICA512/IA-2 Ab or GAD Ab 63(86) 3.92 10.28 6 x 10 -4 
ICA512/IA-2 Ab or IAA 56(77) 2.05 3.21 0.036 
GAD Ab or IAA 58(79) 2.41 4.75 0.014 
ICA512/IA-2 Ab or GAD Ab or IAA 65(89) 5.06 13.30 1 x 10 -4 
ICA alone 45(62) - - -
Data are n (%). Ab, autoantibodies
Prediction of insulin-deficiency in LADA
 LADA (latent autoimmune diabetes in adults) is a 
special subgroup of diabetes, which could represent a 
late manifestation of type 1 diabetes"'. The autoimmune 
destructive process is much slower, making it some-
times difficult to distinguish clinically between type 1 
and type 2 diabetes. The development of clinical 
symptoms is often insidious, without features typical 
or type 1 diabetes such as severe polydipsia, polyuria, 
weight reduction, or ketoscidosis. Such patients who 
have a slowly evolving form of type 1 diabetes retain 
insulin secretion in their initial stage and often diag-
nosed as type 2 diabetes based on clinical features"'. 
Our cross-sectional study revealed that prevalence 
of GAD autoantibodies is 3-4 % among Japanese pa-
tients originally classified as having type 2 diabetes. 
A high levels of GAD autoantibodies or both positive 
for GAD autoantibodies and ICA is often associated 
with low insulin secretion of GAD autoantibody-
positive patients46'. Kobayashi and coworkers suggest 
that small dose insulin treatment may be helpful to 
preserve C-peptide secretion in islet-autoantibody 
positive diabetic patients in adults who still retain 
their insulin secretion 4". Based on these results, a lon-
gitudinal nation-wide study of LADA commenced in 
1996 by 14 centers across west Japan area. A total of 
2,658 Japanese type 2 diabetic patients treated by diet 
and/or OHA were evaluated the GAD autoantibodies 
and assessed prospectively whether the presence of 
GAD autoantibodies could predict the requirement of 
future insulin treatment. The overall prevalence of 
GAD autoantibodies among patients with non-insulin 
requiring diabetes was 2.0 %, and 2.8 % of the patients 
with disease duration of < 5 years and 0.9 % with a 
longer duration of diabetes. As shown in Figure 2, the 
patients with higher levels of GAD autoantibodies 
( > 20 units/ml) more often progressed to insulin
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dependency than the lower titer group (<20 units/ml) 
during the follow up period"'. However, there is a cer-
tain number of patients with high titer of GAD 
autoantibodies who do not progressed to insulin de-
pendency for many years and the predictive value of 
GAD autoantibody positivity for future insulin re-
quirement is estimated about 67 % by Baye's theory. 
Thus accurate predictive strategies of future insulin 
deficiency in patients with LADA using autoantibody 
epitope analysis, genetic determination, or T cell assay 
are required for the effective immune intervention").
 (%) 
    100 -------, 
I 
                  L 
GADAb < 20 U 
  50 
                               GADAb z20 U 0 
5 
                                 P=0.02 
0 a 
0 1 2 3
Follow up period (years)
GADAbZ20 n 25 21 4 2 
GADAb <20 n 20 15 6 4
Figure 2. Life table analysis of the risk of insulin-requiring 
in GAD autoantibody-positive diabetic patients initially diag-
nosed as having type 2 diabetes. Adapted from Takino et al, 
Diabet Med 19: 730-734, 2002
Conclusion
 Japanese type 1 diabetes has genetically and 
immunologically heterogenous mechanisms that result 
in different clinical course of / -cell destruction. A 
number of susceptibility genes and the different 
expression of anti-islet autoantibodies may influence 
the heterogeneity of disease phenotype such as early-
onset versus adult-onset or abrupt-onset versus slow-
onset. It is now possible to predict the ongoing 
/9 -cell destruction using combined measurement of 
autoantibodies to multiple islet autoantigens. A re-
markable number of new agents for immunotherapy 
are being introduced into clinical practice. If a safe 
and effective therapy is identified, we should consider 
the use of agent for high risk individuals to prevent 
development of diabetes as well as for the patients 
with type 1 diabetes in adults who are often diag-
nosed as type 2 diabetes to preserve residual j -cell 
function.
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